Clinical Trial: High-dose cyclophosphamide - National Multiple Sclerosis Society

Skip to navigation Skip to content

Clinical Trial: High-dose cyclophosphamide

Share

Details
Type of MS: RRMS
Treatment mode of action: To affect immune function
Number of Subjects: 10
Medication: Cyclophosphamide
Location: MD
Contact Information
Chitra Krishnan
(410) 955-3129

Funding:

Johns Hopkins GCRC

Description

Pilot study in aggressive MS

Share